Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Income (Loss)

v2.4.0.6
Consolidated Statements of Operations and Comprehensive Income (Loss) (USD $)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Net sales $ 1,321.3 $ 1,237.5 $ 1,167.0
Cost of goods sold (902.0) (830.5) (775.1)
Gross profit 419.3 407.0 391.9
Selling, general and administrative expenses (218.6) (191.0) (173.4)
Research and development expenses (37.2) (30.4) (28.0)
Asset impairments (16.9) (14.3)  
Asbestos adjustments (117.1) (15.8) (85.8)
Operating income 29.5 155.5 104.7
Interest expense (5.5) (11.2) (9.0)
Interest income 7.9 3.8 4.6
Other income (expense) 1.8 3.0 (3.7)
Income before income taxes 33.7 151.1 96.6
Income tax benefit (expense) 11.8 453.2 (443.6)
Net income (loss) 45.5 604.3 (347.0)
Net income (loss) per share      
Basic $ 0.10 $ 1.39 $ (0.80)
Diluted $ 0.10 $ 1.38 $ (0.80)
Weighted average common shares outstanding (Millions):      
Basic 439.2 436.2 435.6
Diluted 440.6 437.9 435.6
Comprehensive income (loss):      
Net income (loss) 45.5 604.3 (347.0)
Pension and post-retirement benefit adjustments      1.3
Unrealised gain on investments 0.9 0.1 1.3
Currency translation adjustments (2.9) (5.9) (6.6)
Comprehensive income (loss) $ 43.5 $ 598.5 $ (351.0)